Patent 7838049 was granted and assigned to Taipei Medical University on November, 2010 by the United States Patent and Trademark Office.
The invention provides a Pyracantha koidzumii extract and new compounds isolated from the extract and their derivatives. This extract and these compounds have activity in inhibiting tyrosinase.